-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Gefurulimab is approved by the European Union for myasthenia gravis.

智通财经·09/18/2026 10:25:05
语音播报
AstraZeneca Gefurulimab is approved by the European Union for myasthenia gravis.